Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases

NCT06611657 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Whole Brain Radiotherapy

Interventions

DRUG: Antirotinib hydrochloride

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences